Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

March 31, 2005

Conditions
Healthy
Interventions
DRUG

CDB-2914

DRUG

COB-2914

Trial Locations (1)

20892

National Institute of Child Health and Human Development (NICHD), Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00041899 - Comparison of Blood Levels of Two Formulations of the Selective Hormone Receptor Modulator CDB-2914 | Biotech Hunter | Biotech Hunter